Open original FDA record ↗Recall record
- FDA identifier
- Z-1891-2017
- Company in FDA record
- PEROUSE MEDICAL
- FDA record creation date
- Apr 28, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Complaints regarding broken blister.
Source facts
- Action
- Consignees were notified of the recall on April 5, 2017. They were informed of the issue and asked to take the following steps: 1. Inspect your stock to determine if you still have in your ownership devices among which the references and batch codes are listed in front page; 2. Control the potential damage of the blister according to the pictures above and the instructions mentioned on the labeling and the Instruction For Use: any damaged and/or cracked blister must be immediately discarded; 3. Use the compliant products without risk, after control. Indeed, the primary packaging will not deteriorate in time. If, to date, there is no crack in the blister, then the integrity of the product is not compromised; 4- Do not use the non-compliant products; 5. Complete and sign the attached reply form, then return it within 5 working days following the reception of this letter, and keep a copy; 6. Contact customer service for the modalities of return, replacement and associated support at +33 (0)4.72.39.74.13 or by fax at +33 (0}3.44.08.17.67 or by email at iblayon@vvgon.com (CC mhpourriere@vygon.com); 7. Communicate the safety information to any person concerned in your company and to all end customers to which the product were transferred.
- Initiated
- 2017-04-05
- Root cause
- Packaging change control
- Terminated
- 2021-02-01
- Distribution
- US: AZ (shipped through Belgium to USA), MN, TN
- Recall number
- Z-1891-2017
- Recall status
- Terminated
- CDRH record ID
- 154975
- FDA record created
- 2017-04-28
- Recall event number
- 77100